Federal Judge Dismisses Pharmaceutical Industry Lawsuit Against Medicare Drug Price Negotiation Program
In a significant legal development, a federal court in Austin, Texas, has dismissed a lawsuit filed by the Pharmaceutical Research and Manufacturers of America (PhRMA) [more…]
Alma Metals extends high-grade copper-molybdenum zone at the Briggs project
Final assays from 2023 core drilling extends higher-grade zone of copper-molybdenum mineralisation Zone extended along eastern contact zone of the Briggs Central deposit to ~500m [more…]
Closing Bell: ASX embraces Star Tech and Return of the Jobless
ASX rises 0.77pc, hefted heavenward with the help of a huge tech buy InfoTech was the best of the sectors, up 6.81pc by day’s end [more…]
ASX Large Caps: Another win day for ASX, but BHP down after revealing impairments worth billions
ASX closes higher as unemployment rises Altium to be acquired by Japanese firm Japan’s economy slips to third place behind Germany The ASX 200 [more…]
Long Shortz with Torque Metals: Lots of Torque about holes at New Dawn
Stockhead’s Ashtyn Hiron sits down with Torque Metals (ASX:TOR) Managing Director Cristian Moreno to get the short end of the long story on the company’s [more…]
Resources Top 4: Lithium hunter James Bay Minerals makes a yellowcake detour in Quebec
James Bay Minerals is leading the ressie gains pack today, which is good, because it actually has fresh news Artemis Resources, Prodigy Gold and Olympio [more…]
ASX Small Caps Lunch Wrap: Which pastor was putting the meth in Methodist this week?
Local markets have opened higher this morning, thanks to a change of heart among US tech investors that allowed New York’s indices to retake some [more…]
Canada Unearthed: SSR crumbles as heap leach pad disaster shuts Turkish gold mine
Our Canada Unearthed column wraps the news driving mining and exploration stocks listed in Canada, mostly on the TSX and TSX.V. The Aussie gold sector, [more…]
Explorers Podcast: Is Red Metal’s Sybella the belle of the rare earths ball?
Stockhead’s ‘Garimpeiro’ columnist Barry FitzGerald is back in the studio for another instalment of The Explorers Podcast. In this episode Barry chats to Robert Rutherford, [more…]
ASX Health Stocks: Clarity’s imaging agent can identify prostate cancer lesions at double the rate
Clarity says initial data from Phase 1/2 trial is positive Opthea completes enrolment of all patients in the COAST Phase 3 trial ProMedicus locks in [more…]
